| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 药品研发服务(元) | 112,164,235.54 | 264,918,075.48 | 148,889,953.70 |
| 医药商品流通(元) | 109,928,761.89 | 130,243,242.48 | 51,399,109.11 |
| 医药制造业(元) | 538,222,890.00 | 1,541,058,963.66 | 724,033,412.94 |
| 营业成本(元) | |||
| 药品研发服务(元) | 73,066,709.41 | 176,168,452.39 | 92,553,246.95 |
| 医药商品流通(元) | 92,962,278.40 | 109,790,204.05 | 44,462,962.28 |
| 医药制造业(元) | 407,197,465.15 | 1,156,359,742.62 | 528,398,293.53 |
| 毛利(元) | |||
| 药品研发服务(元) | 39,097,526.13 | 88,749,623.09 | 56,336,706.75 |
| 医药商品流通(元) | 16,966,483.49 | 20,453,038.43 | 6,936,146.83 |
| 医药制造业(元) | 131,025,424.85 | 384,699,221.04 | 195,635,119.41 |
| 毛利率(%) | |||
| 药品研发服务(%) | 34.86 | 33.50 | 37.84 |
| 医药商品流通(%) | 15.43 | 15.70 | 13.49 |
| 医药制造业(%) | 24.34 | 24.96 | 27.02 |
| 收入构成(%) | |||
| 药品研发服务(%) | 14.75 | 13.68 | 16.11 |
| 医药商品流通(%) | 14.46 | 6.73 | 5.56 |
| 医药制造业(%) | 70.79 | 79.59 | 78.33 |
| 毛利构成(%) | |||
| 药品研发服务(%) | 20.90 | 17.97 | 21.76 |
| 医药商品流通(%) | 9.07 | 4.14 | 2.68 |
| 医药制造业(%) | 70.03 | 77.89 | 75.56 |